Navigation Links
VIRxSYS to Host a Web Conference to Announce Clinical Trial Update
Date:7/21/2008

Summary of data from five 2008 conferences

GAITHERSBURG, Md., July 21 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present an update on the VRX496 Phase I and Phase II clinical trials for the media and members of the advocacy community. VRX496 is an investigational gene therapy for the treatment of AIDS. The presentation will take place on Thursday, July 24, 2008 at 11 a.m. EDT. The presentation can be accessed through a secure web site, https://www.livemeeting.com/cc/vcc/join?id=w5395452&role=attend&pw=A539545 and toll-free conference line: (800) 768-6570, using the passcode 5395452.

The speakers will be:

-- Gary McGarrity, PhD, Executive Vice President for Scientific Affairs, VIRxSYS

-- Carl June, MD, Professor, Department of Pathology and Laboratory Medicine, University of Pennsylvania

"Over the last six months we have presented clinical trial update for VRX496 and preclinical development update for VRX1023 at five conferences in three countries. We wanted to take this opportunity to summarize what we have shown over the last six months as well as talk about what we have learned at the conferences regarding how VRX496 and VRX1023 might play in the treatment of HIV infection," said Riku Rautsola, PhD, President and CEO of VIRxSYS. "These conferences have not just been an opportunity to present our data, but we have also learned more about what we do and gotten feedback from leaders in the field. For example, in Paris, Dr. Fauci's presentation focused on the discovery and identification of a new immune cell receptor that binds to HIV, a cell adhesion molecule known as integrin alpha 4 beta 7 that is found to direct CD4 T cell traffic to GALT and enhance cellular interaction through forming synapses between T cells. This was interesti
'/>"/>

SOURCE VIRxSYS Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia
2. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
5. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
6. ViroPharma to Present at Three Upcoming Healthcare Conferences
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
9. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
10. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
11. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
(Date:8/21/2014)... BreedIT Corp., (OTCQB: BRDT) ... worldwide license holder and distributor of highly sophisticated ... today is pleased to announce the formation of ... a leading Israeli medical Cannabis breeder. ... breeds of medical Cannabis to meet the requests ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... content that is written by marketing experts for marketers ... affiliate links has caught the attention of Shane Michaels, ... involved with Internet marketing in any way knows that ... failure in the industry,” reports Michaels. “But even though ...
(Date:8/22/2014)... Buying a policy for different life insurance products can ... coverage types by insurers in the U.S. The Quotes Pros ... the public using its sortable tool at http://quotespros.com/life-insurance.html . ... is expected to promote the discounts and special offerings for ... The system is designed to help an adult locate a ...
(Date:8/22/2014)... 2014 Millennium Treatment Group has recently noticed ... high level of drug use among teenagers. The treatment facility ... addiction and work to minimize drug abuse. , America is ... drug addiction in history. According to the National Institute ... Americans aged 12 or older—or 9.2 percent of the population—had ...
(Date:8/22/2014)... Amy Norton HealthDay ... -- A growing number of Americans on work disability ... study. Researchers found that between 2007 and 2011, ... Insurance benefits were prescribed narcotic painkillers each year. And ... percent in 2007 to 23 percent in 2011. ...
(Date:8/22/2014)... Many Americans know little about how Ebola is transmitted and ... the United States, a new survey shows. About four ... be a major Ebola outbreak in the United States, and ... will get sick with the deadly virus in the next ... poll. However, those opinions don,t match reality, the Harvard ...
Breaking Medicine News(10 mins):Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Many Americans Harbor Unfounded Fears About Ebola Outbreak: Survey 2
... Life & Health Insurance Company (ELH), a subsidiary of Eastern ... that it will add vision to the ELH line of ... plan and a vision discount program, both utilizing the VSP ... product portfolio enables employers to offer one of the most ...
... Dec. 29 Dynatronics Corporation (Nasdaq: DYNT ) ... filed by NASDAQ with the SEC, gives the company ... $1 per share minimum bid rule."We are pleased that ... light of the current market environment," stated Kelvyn H. ...
... may help spread the word about warfarin,s possible complications ... pamphlet has been published to help Spanish-speaking patients understand ... blood thinner warfarin. , Millions of Americans take warfarin, ... an irregular heartbeat (known as atrial fibrillation), they,ve had ...
... Latest bid to force TomoTherapy to consider strategic alternativesMADISON, Wis., ... Avalon Capital Group, announced that on December 23, 2008 it ... TomoTherapy Inc. (Nasdaq: TOMO ). This step is ... value for the company,s shareholders in the wake of the ...
... widespread media attention given to studies that have indicated ... new study shows just one-third of children who are ... pediatrician. The study, led by researchers at The ... Medicine in Cleveland, also stresses that this failure to ...
... drug use higher among those whose families don,t accept ... young adults whose families rejected them when they were ... sex, illegal drug use and suicide attempts, new research ... negative reaction to a child,s sexuality directly causes problems ...
Cached Medicine News:Health News:Eastern Life & Health Introduces New Vision Product 2Health News:Eastern Life & Health Introduces New Vision Product 3Health News:NASDAQ Gives Dynatronics a Second Three-Month Extension for Minimum Bid Price Compliance 2Health News:Guide on Blood Thinner Now Available in Spanish 2Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 2Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 3Health News:Can't chalk it up to 'baby fat' 2Health News:Rejection of Gay Teens Linked to Later Troubles 2Health News:Rejection of Gay Teens Linked to Later Troubles 3
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.5 mm, 1 x 2 teeth set at 45 degrees. Serrated handle with polished finish....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees....
0.12 mm, 1 x 2 teeth. Serrated handle with polished finish....
Medicine Products: